PDXDC2P-NPIPB14P readthrough, transcribed pseudogene (PDXDC2P-NPIPB14P)

PDXDC2P-NPIPB14P readthrough, transcribed pseudogene, represents a naturally occurring fusion transcript resulting from readthrough transcription between two pseudogenes: PDXDC2P (pyridoxal dependent decarboxylase domain containing 2, pseudogene) and NPIPB14P (nuclear pore complex interacting protein family, member B14, pseudogene)[1]. This readthrough is classified as a transcribed pseudogene, and its transcript is not expected to encode a functional protein[1]. The individual pseudogene loci are not curated as transcribed regions, and the fusion likely lacks biological activity at the protein level[1]. Although some transcribed pseudogenes elsewhere in the genome can play regulatory functions at the RNA level, notably by acting as microRNA decoys or competing endogenous RNAs in rare cases[3][4], there is no evidence that PDXDC2P-NPIPB14P has such activity, nor is it considered a receptor, enzyme, transporter, or other canonical therapeutic target[1][2].\n\n**Notes**:\n- This locus is a pseudogene readthrough and not a protein-coding or functional gene product[1].\n- No known therapeutic drugs, biomarker value, or direct disease association is described for this locus.\n- If your context requires a molecular target for drug discovery, this is not a relevant entry.\n- The target name and aliases are correct as applied to the readthrough pseudogene; however, it is not a bona fide therapeutic target.

Other names

PDXDC2P-NPIPB14P readthrough, transcribed pseudogenePutative pyridoxal-dependent decarboxylase domain-containing protein 2Pyridoxal-dependent decarboxylase domain-containing 2 pseudogenePDXDC2P-NPIPB14P